Who is sponsoring ARCTiC?

ARCTiC is sponsored by University of Colorado, Boulder.

What condition does ARCTiC study?

ARCTiC studies Sleep, Anxiety, Depression, Pain.

What drugs are being tested in ARCTiC?

Interventions: fsCBD Cannabidiol, Placebo, bsCBD Cannabidiol.

What is the status of ARCTiC?

ARCTiC is currently RECRUITING.

Last reviewed 2025-08-01 · How we verify

Cannabis for Palliative Care in Cancer (ARCTiC)

NCT06266611 PHASE2 RECRUITING

Many cancer patients suffer from pain, sleep, and mood problems and are using cannabis to relieve these symptoms. Cannabis may provide such relief but may also produce negative side effects including cognitive impairment, an especially problematic issue for cancer patients, indicating more research on cannabis use in the cancer context is required. In this endeavor, the present study seeks to compare the use of hemp-derived CBD (Cannabidiol) with and without THC (Delta-9-tetrahydrocannabinol) versus placebo on measures of sleep, pain, mood, subjective and objective cognitive functioning, and quality of life within 185 cancer patients.

Details

Lead sponsor	University of Colorado, Boulder
Phase	PHASE2
Status	RECRUITING
Enrolment	185
Start date	Mon Sep 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Jun 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Sleep
Anxiety
Depression
Pain

Interventions

fsCBD Cannabidiol
Placebo
bsCBD Cannabidiol

Countries

United States